Exact Mass: 306.1573
Exact Mass Matches: 306.1573
Found 103 metabolites which its exact mass value is equals to given mass value 306.1573,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Inproquone
2,5-bis(aziridin-1-yl)-3,6-dipropoxycyclohexa-2,5-diene-1,4-dione
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
(2E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
(2E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
methyl 2-chloro-2-carboxy-6,10-dimethylundecanoate
methyl 2-chloro-2-carboxy-6,10-dimethylundecanoate
(E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
NCGC00170014-03!(E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
(E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide [IIN-based on: CCMSLIB00000848670]
NCGC00170014-03!(E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide [IIN-based on: CCMSLIB00000848670]
(E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide [IIN-based on: CCMSLIB00000848669]
NCGC00170014-03!(E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide [IIN-based on: CCMSLIB00000848669]
(E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide [IIN-based: Match]
NCGC00170014-03!(E)-N-(4-acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide [IIN-based: Match]
(2E)-N-(4-Acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide
(2E)-N-(4-Acetamidobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide
(-)-1,2-BIS[(2R,5R)-2,5-DIMETHYLPHOSPHOLANO]BENZENE
(-)-1,2-BIS[(2R,5R)-2,5-DIMETHYLPHOSPHOLANO]BENZENE
Ruxolitinib
Ruxolitinib
D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AH - Agents for dermatitis, excluding corticosteroids L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EJ - Janus-associated kinase (jak) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-(8-(TERT-BUTOXYCARBONYL)-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-YL)PROPANOIC ACID
3-(8-(TERT-BUTOXYCARBONYL)-5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-YL)PROPANOIC ACID
methyl 2-[4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetate
methyl 2-[4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetate
Urea, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-N-(3-methylphenyl)- (9CI)
Urea, N-(5,7-dimethyl-1,8-naphthyridin-2-yl)-N-(3-methylphenyl)- (9CI)
4-(3-Ethylthioureido)phenylboronic acid, pinacol ester
4-(3-Ethylthioureido)phenylboronic acid, pinacol ester
2-hydroxyethyl-[2-hydroxy-3-[2-hydroxyethyl(dimethyl)azaniumyl]propyl]-dimethylazanium,dichloride
2-hydroxyethyl-[2-hydroxy-3-[2-hydroxyethyl(dimethyl)azaniumyl]propyl]-dimethylazanium,dichloride
2,2,4,4,6,6-Hexaethyl-1,3,5,2,4,6-trioxatrisilinane
2,2,4,4,6,6-Hexaethyl-1,3,5,2,4,6-trioxatrisilinane
2,3-dimethyl-1-[(2-methylpropan-2-yl)oxycarbonyl]-3,4-dihydro-2H-quinoxaline-6-carboxylic acid
2,3-dimethyl-1-[(2-methylpropan-2-yl)oxycarbonyl]-3,4-dihydro-2H-quinoxaline-6-carboxylic acid
3-benzo[1,3]dioxol-5-yl-piperazine-1-carboxylic acid tert-butyl ester
3-benzo[1,3]dioxol-5-yl-piperazine-1-carboxylic acid tert-butyl ester
4-[(2,4-Dimethylphenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one
4-[(2,4-Dimethylphenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one
BENZYL 4-(METHOXY(METHYL)CARBAMOYL)PIPERIDINE-1-CARBOXYLATE
BENZYL 4-(METHOXY(METHYL)CARBAMOYL)PIPERIDINE-1-CARBOXYLATE
METHYL 3-ETHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
METHYL 3-ETHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
(7R,9R)-7,9-METHANO-3,8,8-TRIMETHYL-4A,5,8,9-TETRAHYDRO-1H,7H-PYRANO[4,3-B]BENZOPYRAN-1-ONE
(7R,9R)-7,9-METHANO-3,8,8-TRIMETHYL-4A,5,8,9-TETRAHYDRO-1H,7H-PYRANO[4,3-B]BENZOPYRAN-1-ONE
1-(TERT-BUTOXYCARBONYL)-4-(PYRIDIN-4-YL)PIPERIDINE-4-CARBOXYLIC ACID
1-(TERT-BUTOXYCARBONYL)-4-(PYRIDIN-4-YL)PIPERIDINE-4-CARBOXYLIC ACID
1-(2-{2-[(Allyloxy)methyl]-4-nitrophenoxy}ethyl)pyrrolidine
1-(2-{2-[(Allyloxy)methyl]-4-nitrophenoxy}ethyl)pyrrolidine
ETHYL 2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ACETATE
ETHYL 2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ACETATE
1H-Benzotriazole,1-[(3S,5R,7aR)-hexahydro-3-phenylpyrrolo[2,1-b]oxazol-5-yl]-
1H-Benzotriazole,1-[(3S,5R,7aR)-hexahydro-3-phenylpyrrolo[2,1-b]oxazol-5-yl]-
tert-Butyl 4-(3-formyl-4-hydroxyphenyl)piperazine-1-carboxylate
tert-Butyl 4-(3-formyl-4-hydroxyphenyl)piperazine-1-carboxylate
1-(TERT-BUTOXYCARBONYL)-4-(PYRIDIN-2-YL)PIPERIDINE-4-CARBOXYLIC ACID
1-(TERT-BUTOXYCARBONYL)-4-(PYRIDIN-2-YL)PIPERIDINE-4-CARBOXYLIC ACID
5-[4-(2-METHOXY-PHENYL)-PIPERAZIN-1-YL]-5-OXO-PENTANOIC ACID
5-[4-(2-METHOXY-PHENYL)-PIPERAZIN-1-YL]-5-OXO-PENTANOIC ACID
1-(1-Piperazinyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
1-(1-Piperazinyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ACETIC ACID ETHYL ESTER
[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ACETIC ACID ETHYL ESTER
(+)-1,2-bis-((2S,5S)-2,5-Dimethylphospholano)benzene
(+)-1,2-bis-((2S,5S)-2,5-Dimethylphospholano)benzene
Deuruxolitinib
Deuruxolitinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor
3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]propanenitrile
3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]propanenitrile
N~3~-[3-(5-Methoxypyridin-3-Yl)benzyl]pyridine-2,3-Diamine
N~3~-[3-(5-Methoxypyridin-3-Yl)benzyl]pyridine-2,3-Diamine
[3-Carboxy-2-(4-carboxy-3-hydroxypentanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(4-carboxy-3-hydroxypentanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(5-carboxy-3-hydroxypentanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(5-carboxy-3-hydroxypentanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(3-carboxy-3-hydroxypentanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-(3-carboxy-3-hydroxypentanoyl)oxypropyl]-trimethylazanium
4-[[4-(1-Pyrrolidinyl)-2-quinazolinyl]amino]phenol
4-[[4-(1-Pyrrolidinyl)-2-quinazolinyl]amino]phenol
N-(2,3-dihydro-1H-inden-5-yl)-5,7-dimethyl-3-pyrazolo[1,5-a]pyrimidinecarboxamide
N-(2,3-dihydro-1H-inden-5-yl)-5,7-dimethyl-3-pyrazolo[1,5-a]pyrimidinecarboxamide
1-[5-[2-(tert-butylamino)-4H-1,3,4-thiadiazin-5-ylidene]-2,4-dimethyl-3-pyrrolyl]ethanone
1-[5-[2-(tert-butylamino)-4H-1,3,4-thiadiazin-5-ylidene]-2,4-dimethyl-3-pyrrolyl]ethanone
N-[(E)-benzylideneamino]-1-ethyl-2-methylbenzimidazole-5-carboxamide
N-[(E)-benzylideneamino]-1-ethyl-2-methylbenzimidazole-5-carboxamide
8-methyl-6-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
8-methyl-6-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(3r,6r)-3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
(3r,6r)-3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
6-methyl-8-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
6-methyl-8-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
3-[(3-hydroxy-4-methoxyphenyl)methyl]-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol
3-[(3-hydroxy-4-methoxyphenyl)methyl]-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol
(3s,6r)-3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
(3s,6r)-3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
12-methyl-8-methylidene-3-pentyl-6,16-dioxatetracyclo[11.2.1.0⁵,¹⁵.0⁹,¹⁴]hexadeca-1(15),2,4,9,11,13-hexaene
12-methyl-8-methylidene-3-pentyl-6,16-dioxatetracyclo[11.2.1.0⁵,¹⁵.0⁹,¹⁴]hexadeca-1(15),2,4,9,11,13-hexaene
{7-phenyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-dien-2-yl}acetic acid
{7-phenyltetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-dien-2-yl}acetic acid
(3r,5s,6s,12s)-5,6-dihydroxy-3-[(2-hydroxyethyl)sulfanyl]-12-methyl-1-oxacyclododecan-2-one
(3r,5s,6s,12s)-5,6-dihydroxy-3-[(2-hydroxyethyl)sulfanyl]-12-methyl-1-oxacyclododecan-2-one
(4z,6e,8e)-3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
(4z,6e,8e)-3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
[(1s,6r,7r,8r)-8-[(2e,4e)-5-phenylpenta-2,4-dien-1-yl]bicyclo[4.2.0]octa-2,4-dien-7-yl]acetic acid
[(1s,6r,7r,8r)-8-[(2e,4e)-5-phenylpenta-2,4-dien-1-yl]bicyclo[4.2.0]octa-2,4-dien-7-yl]acetic acid
3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
(3s,6s)-3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
(3s,6s)-3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
3-benzyl-3,5-dihydroxy-6-(methylamino)-6-(2-methylpropyl)-1,4-oxazin-2-one
3-benzyl-3,5-dihydroxy-6-(methylamino)-6-(2-methylpropyl)-1,4-oxazin-2-one
(3s,4e,6e,8e,10s)-3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
(3s,4e,6e,8e,10s)-3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
(3s,6s)-3-benzyl-3,5-dihydroxy-6-(methylamino)-6-(2-methylpropyl)-1,4-oxazin-2-one
(3s,6s)-3-benzyl-3,5-dihydroxy-6-(methylamino)-6-(2-methylpropyl)-1,4-oxazin-2-one
(3r,4z,6e,8e,10s)-3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
(3r,4z,6e,8e,10s)-3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
(2s)-8-methyl-6-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(2s)-8-methyl-6-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(4z,6z,8e)-3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
(4z,6z,8e)-3,10-dihydroxy-2,2,4-trimethyl-10-(1,3-oxazol-5-yl)deca-4,6,8-trienimidic acid
(3r,6s)-3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
(3r,6s)-3-benzyl-6-methoxy-6-(2-methylpropyl)pyrazine-2,3,5-triol
(3r,6r)-3-[(3-hydroxy-4-methoxyphenyl)methyl]-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol
(3r,6r)-3-[(3-hydroxy-4-methoxyphenyl)methyl]-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol
(3r,6r)-3-benzyl-3,5-dihydroxy-6-(methylamino)-6-(2-methylpropyl)-1,4-oxazin-2-one
(3r,6r)-3-benzyl-3,5-dihydroxy-6-(methylamino)-6-(2-methylpropyl)-1,4-oxazin-2-one
[8-(5-phenylpenta-2,4-dien-1-yl)bicyclo[4.2.0]octa-2,4-dien-7-yl]acetic acid
[8-(5-phenylpenta-2,4-dien-1-yl)bicyclo[4.2.0]octa-2,4-dien-7-yl]acetic acid
(2s)-6-methyl-8-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(2s)-6-methyl-8-(3-methylbut-2-en-1-yl)-2-phenyl-2,3-dihydro-1-benzopyran-4-one
